JAK2 and Insulin resistance: Geng et al. [48] and Xiong et al. [49] showed that inactivated JAK2 reduced inflammatory responses in cardiac muscle cells and macrophages, which was conductive to finding out a new target therapy against cardiac hypertrophy and insulin resistance.